Chemed Corporation (FRA:CXM)

Chemed Statistics

Total Valuation

Chemed has a market cap or net worth of EUR 5.44 billion. The enterprise value is 5.36 billion.

Market Cap	5.44B
Enterprise Value	5.36B

Important Dates

The next estimated earnings date is Tuesday, October 28, 2025.

Earnings Date	Oct 28, 2025
Ex-Dividend Date	Aug 11, 2025

Share Statistics

Current Share Class	14.52M
Shares Outstanding	n/a
Shares Change (YoY)	-2.35%
Shares Change (QoQ)	-0.41%
Owned by Insiders (%)	1.51%
Owned by Institutions (%)	97.21%
Float	14.29M

Valuation Ratios

The trailing PE ratio is 22.02 and the forward PE ratio is 18.26.

PE Ratio	22.02
Forward PE	18.26
PS Ratio	2.55
PB Ratio	5.34
P/TBV Ratio	14.40
P/FCF Ratio	17.22
P/OCF Ratio	14.98
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.41, with an EV/FCF ratio of 16.93.

EV / Earnings	21.66
EV / Sales	2.47
EV / EBITDA	12.41
EV / EBIT	16.59
EV / FCF	16.93

Financial Position

The company has a current ratio of 1.86, with a Debt / Equity ratio of 0.12.

Current Ratio	1.86
Quick Ratio	1.65
Debt / Equity	0.12
Debt / EBITDA	0.29
Debt / FCF	0.39
Interest Coverage	220.65

Financial Efficiency

Return on equity (ROE) is 24.14% and return on invested capital (ROIC) is 17.36%.

Return on Equity (ROE)	24.14%
Return on Assets (ROA)	13.56%
Return on Invested Capital (ROIC)	17.36%
Return on Capital Employed (ROCE)	25.77%
Revenue Per Employee	136,279
Profits Per Employee	15,752
Employee Count	15,695
Asset Turnover	1.45
Inventory Turnover	167.65

Taxes

In the past 12 months, Chemed has paid 83.10 million in taxes.

Income Tax	83.10M
Effective Tax Rate	25.16%

Stock Price Statistics

The stock price has decreased by -31.38% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-31.38%
50-Day Moving Average	380.56
200-Day Moving Average	461.80
Relative Strength Index (RSI)	48.41
Average Volume (20 Days)	5

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.19

Income Statement

In the last 12 months, Chemed had revenue of EUR 2.14 billion and earned 247.23 million in profits. Earnings per share was 16.58.

Revenue	2.14B
Gross Profit	719.70M
Operating Income	319.02M
Pretax Income	330.33M
Net Income	247.23M
EBITDA	369.69M
EBIT	319.02M
Earnings Per Share (EPS)	16.58

Balance Sheet

The company has 212.79 million in cash and 123.95 million in debt, giving a net cash position of 88.85 million.

Cash & Cash Equivalents	212.79M
Total Debt	123.95M
Net Cash	88.85M
Net Cash Per Share	n/a
Equity (Book Value)	1.02B
Book Value Per Share	70.30
Working Capital	193.71M

Cash Flow

In the last 12 months, operating cash flow was 363.40 million and capital expenditures -47.17 million, giving a free cash flow of 316.24 million.

Operating Cash Flow	363.40M
Capital Expenditures	-47.17M
Free Cash Flow	316.24M
FCF Per Share	n/a

Margins

Gross margin is 33.65%, with operating and profit margins of 14.92% and 11.56%.

Gross Margin	33.65%
Operating Margin	14.92%
Pretax Margin	15.44%
Profit Margin	11.56%
EBITDA Margin	17.28%
EBIT Margin	14.92%
FCF Margin	14.79%

Dividends & Yields

This stock pays an annual dividend of 1.91, which amounts to a dividend yield of 0.51%.

Dividend Per Share	1.91
Dividend Yield	0.51%
Dividend Growth (YoY)	21.56%
Years of Dividend Growth	16
Payout Ratio	10.17%
Buyback Yield	2.35%
Shareholder Yield	2.86%
Earnings Yield	4.54%
FCF Yield	5.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 12, 2005. It was a forward split with a ratio of 2.

Last Split Date	May 12, 2005
Split Type	Forward
Split Ratio	2

Scores

Chemed has an Altman Z-Score of 14.38 and a Piotroski F-Score of 6.

Altman Z-Score	14.38
Piotroski F-Score	6